investerarpengarslfm.web.app

Carl Borrebaeck tilldelades priset med motiveringen att han är en flerfaldigt framgångsrik entreprenör som bidragit till skapandet av en rad nya life science-företag, inklusive, bl.a. Alligator Bioscience, Immunovia, BioInvent och SenzaGen, Även hans ansträngningar för att bygga vetenskapliga nätverk, bland annat CREATE Health, Medicon Village, NOME (Nordic Mentor Network for

5804

Carl Borrebaeck Research focus Our research focus on Precision Medicine, Immuno-Oncology, Early Diagnosis and Biomarker Discovery within oncology and other complex diseases.

Carl Borrebaeck is a co-founder of Alligator and a board member of the Royal Swedish Academy of Engineering Sciences (IVA) and former Vice-Chancellor of Lund University. In 2009 Carl Borrebaeck was awarded AkzoNobels Science Prize and 2012 he received IVA´s gold medal for his pioneering research on biomarkers. Professor Carl Borrebaeck and Dr Ulrika Axelsson are Director and Deputy Director, respectively, of the CREATE Health Translational Cancer Centre, Lund University, Sweden; a venue with an outstanding record of world-class cancer research. Borrebaeck is a 2009 recipient of the AkzoNobel Science Award and was awarded the 2012 Gold Medal from the Royal Academy of Engineering Sciences in recognition of his ground-breaking research regarding biomarkers. In 2017 he was designated as the Biotech builder of the Year for his entrepreneurship. Carl Borrebaeck – born 1948, Board member since 2001 - is a Swedish graduate engineer from Lund University, Professor at the Department of Immunotechnology and Programme Director of the CREATE Health Translational Cancer Research Centre at Lund University. Carl Borrebaeck is a co-founder of Alligator and a board member of the Royal Swedish Academy of Engineering Sciences (IVA) and former Vice-Chancellor of Lund University.

  1. Kanguru matematik ödülleri
  2. Nar man kan byta vinterdack
  3. Ms invf global opportunity a
  4. Sista slaget i första världskriget
  5. Arduino projects
  6. Kinberg batra idag

Totalt inbringade försäljningarna nästan 1,2 miljoner kronor. Det framgår av Finansinspektionens insynsregister. Carl Borrebaeck brings experience from his time as a board member of Immunovia AB, SenzaGen AB, CB Ocean Capital AB, Alligator Bioscience AB, Clinical Laserthermia Systems AB, Scandion A/S, and commercial experience from a number of IPOs. He has a DSc in biochemistry with a focus on molecular immunology, is a professor and former Vice President at […] copy and paste the html snippet below into your own page: